News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Fyfe Gwen A.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/29/2018 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns:
| Granted 25,000 options to buy
@ $14.55, valued at
$363.8k
Granted 5,000 restricted stock units
@ $0 Exercised 5,000 restricted stock units
@ $0 |
|
03/13/2018 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns:
| Unknown transaction of 10,125 shares
@ $0 Disposed/sold 13,927 restricted stock units
@ $0 |
|
10/27/2017 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns:
| Exercised 5,000 shares
@ $10.47, valued at
$52.4k
Granted 25,000 options to buy
@ $10.47, valued at
$261.8k
Granted 5,000 restricted stock units
@ $0 Exercised 5,000 restricted stock units
@ $0 |
|
06/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/31/2016 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns:
| Exercised 5,000 shares
@ $5.83, valued at
$29.2k
Granted 5,000 restricted stock units
@ $0 Granted 25,000 options to buy
@ $5.95, valued at
$148.8k
Exercised 5,000 restricted stock units
@ $0 |
|
06/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/02/2015 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns:
| Granted 5,000 restricted stock units
@ $0 Granted 25,000 options to buy
@ $5.13, valued at
$128.3k
|
|
06/16/2015 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.
Txns:
| Granted 15,000 options to buy
@ $11.06, valued at
$165.9k
|
|
10/31/2014 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns:
| Granted 25,000 options to buy
@ $3.87, valued at
$96.8k
|
|
06/19/2014 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.
Txns:
| Granted 15,000 options to buy
@ $11.85, valued at
$177.8k
|
|
10/24/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/26/2012 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on ARRAY BIOPHARMA INC
Txns:
| Granted 20,000 options to buy
@ $4.36, valued at
$87.2k
|
|
05/18/2012 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.
Txns:
| Granted 6,000 options to buy
@ $12.94, valued at
$77.6k
|
|
03/12/2012 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $8.87, valued at
$88.7k
|
|
03/12/2012 |
3
| Fyfe Gwen A. (Director) has filed a Form 3 on INFINITY PHARMACEUTICALS, INC. |
10/05/2011 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on PHARMACYCLICS INC
Txns:
| Granted 2,652 options to buy
@ $11.31, valued at
$30k
|
|
07/06/2011 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on PHARMACYCLICS INC
Txns:
| Granted 2,126 options to buy
@ $10.58, valued at
$22.5k
|
|
04/05/2011 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on PHARMACYCLICS INC
Txns:
| Granted 3,743 options to buy
@ $6.01, valued at
$22.5k
|
|
12/13/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/13/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|